DK1248605T3 - Hidtil ukendte sertralinhydrochloridpolymorfer, processer til deres fremstilling, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse - Google Patents

Hidtil ukendte sertralinhydrochloridpolymorfer, processer til deres fremstilling, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse

Info

Publication number
DK1248605T3
DK1248605T3 DK00990336T DK00990336T DK1248605T3 DK 1248605 T3 DK1248605 T3 DK 1248605T3 DK 00990336 T DK00990336 T DK 00990336T DK 00990336 T DK00990336 T DK 00990336T DK 1248605 T3 DK1248605 T3 DK 1248605T3
Authority
DK
Denmark
Prior art keywords
methods
processes
sertraline hydrochloride
preparation
compositions containing
Prior art date
Application number
DK00990336T
Other languages
English (en)
Inventor
Judith Aronhime
Tamar Nidam
Marioana Mendelovici
Claude Singer
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of DK1248605T3 publication Critical patent/DK1248605T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00990336T 1999-12-21 2000-12-21 Hidtil ukendte sertralinhydrochloridpolymorfer, processer til deres fremstilling, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse DK1248605T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17134199P 1999-12-21 1999-12-21
US18733600P 2000-03-06 2000-03-06
US18791000P 2000-03-08 2000-03-08
US19060300P 2000-03-20 2000-03-20
PCT/US2000/035178 WO2001045692A1 (en) 1999-12-21 2000-12-21 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them

Publications (1)

Publication Number Publication Date
DK1248605T3 true DK1248605T3 (da) 2007-03-19

Family

ID=27496950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00990336T DK1248605T3 (da) 1999-12-21 2000-12-21 Hidtil ukendte sertralinhydrochloridpolymorfer, processer til deres fremstilling, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse

Country Status (19)

Country Link
US (2) US6452054B2 (da)
EP (2) EP1797875A3 (da)
JP (2) JP4057295B2 (da)
KR (1) KR100791872B1 (da)
CN (1) CN1434708A (da)
AT (1) ATE354358T1 (da)
AU (1) AU780771B2 (da)
DE (1) DE60033566T2 (da)
DK (1) DK1248605T3 (da)
ES (1) ES2281374T3 (da)
HR (1) HRP20020543A2 (da)
HU (1) HUP0204010A3 (da)
IL (1) IL150332A0 (da)
IS (1) IS6425A (da)
PL (1) PL356452A1 (da)
PT (1) PT1248605E (da)
SK (1) SK8872002A3 (da)
WO (1) WO2001045692A1 (da)
YU (1) YU47902A (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6978342B1 (en) 1995-07-31 2005-12-20 Lexar Media, Inc. Moving sectors within a block of information in a flash memory mass storage architecture
US5845313A (en) 1995-07-31 1998-12-01 Lexar Direct logical block addressing flash memory mass storage architecture
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) * 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
TWI260315B (en) 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
AU780771B2 (en) 1999-12-21 2005-04-14 Teva Pharmaceutical Industries Ltd. Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
CN1232481C (zh) * 2000-03-14 2005-12-21 特瓦制药工业有限公司 制备(+)－顺－舍曲林的方法
EP1397343A1 (en) 2001-05-31 2004-03-17 Orion Corporation Fermion Process for preparing sertraline hydrochloride polymorphic form ii
CA2448300A1 (en) * 2001-05-31 2002-12-05 Orion Corporation Fermion Process for preparing sertraline intermediates
GB0123421D0 (en) 2001-09-28 2001-11-21 Memquest Ltd Power management system
AU2003251290A1 (en) * 2002-04-29 2003-11-17 Teva Pharmaceutical Industries Ltd. Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
JP2007502329A (ja) * 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
EP1660432A2 (en) * 2003-09-05 2006-05-31 Teva Pharmaceutical Industries Limited A recycling process for preparing sertraline
RU2376279C2 (ru) * 2003-11-04 2009-12-20 Сипла Лимитед Способ получения полиморфов ингибитора повторного захвата серотонина (варианты)
US7464306B1 (en) 2004-08-27 2008-12-09 Lexar Media, Inc. Status of overall health of nonvolatile memory
US7345201B2 (en) * 2005-02-23 2008-03-18 Teva Pharmaceutical Industries, Ltd. Processes for preparing sertraline
WO2006103506A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Sertraline-containing pharmaceutical compositions and a process for preparation thereof
GB0507090D0 (en) * 2005-04-07 2005-05-11 Sandoz Ag Process for preparing polymorphic form ll of sertraline hydrochloride
US7518019B2 (en) * 2006-06-01 2009-04-14 Hetero Drugs Limited Processes for preparing sertraline hydrochloride crystalline forms
US20060257475A1 (en) * 2006-08-17 2006-11-16 Boehringer Ingelheim International Gmbh Stable Sertraline Hydrochloride Formulation and Method
CA2594198A1 (en) * 2007-07-20 2009-01-20 Apotex Pharmachem Inc. A novel process for the preparation of sertraline hydrochloride form ii
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5082970A (en) 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
GB9114947D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
HUP0101322A3 (en) 1998-03-18 2002-06-28 Ciba Sc Holding Ag Process for the cis-selective catalytic hydrogenation of cyclohexylidenamines
JP2000026379A (ja) * 1998-07-08 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンメタノール和物および塩酸セルトラリンエタノール和物、ならびにそれらの製法
EP1133459B1 (en) * 1998-11-27 2006-01-11 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride form v
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
TWI260315B (en) * 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
AU780771B2 (en) * 1999-12-21 2005-04-14 Teva Pharmaceutical Industries Ltd. Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
IN192343B (da) 2000-05-26 2004-04-10 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
ATE354358T1 (de) 2007-03-15
HUP0204010A3 (en) 2006-02-28
HUP0204010A2 (hu) 2003-04-28
EP1248605A2 (en) 2002-10-16
JP2007308505A (ja) 2007-11-29
IS6425A (is) 2002-06-18
KR100791872B1 (ko) 2008-01-07
US6452054B2 (en) 2002-09-17
KR20020062356A (ko) 2002-07-25
EP1248605B1 (en) 2007-02-21
EP1248605A4 (en) 2004-11-24
JP4057295B2 (ja) 2008-03-05
AU2737601A (en) 2001-07-03
ES2281374T3 (es) 2007-10-01
WO2001045692A1 (en) 2001-06-28
EP1797875A3 (en) 2007-08-29
CN1434708A (zh) 2003-08-06
IL150332A0 (en) 2002-12-01
US20030023117A1 (en) 2003-01-30
EP1797875A2 (en) 2007-06-20
AU780771B2 (en) 2005-04-14
DE60033566T2 (de) 2007-10-25
SK8872002A3 (en) 2002-12-03
YU47902A (sh) 2005-11-28
JP2003518056A (ja) 2003-06-03
US6858652B2 (en) 2005-02-22
DE60033566D1 (de) 2007-04-05
US20010041815A1 (en) 2001-11-15
PL356452A1 (en) 2004-06-28
HRP20020543A2 (en) 2005-04-30
WO2001045692A9 (en) 2002-07-04
PT1248605E (pt) 2007-03-30

Similar Documents

Publication Publication Date Title
DK1248605T3 (da) Hidtil ukendte sertralinhydrochloridpolymorfer, processer til deres fremstilling, sammensætninger indeholdende dem og fremgangsmåder til deres anvendelse
BR0113234A (pt) Polimorfos de um análogo de epotilona
AR029150A1 (es) Un derivado de piperidina, su empleo, un procedimiento para prepararlo y una composicin farmaceutica que lo comprende.
BR0108679A (pt) Novos compostos
BR0113176A (pt) Compostos biciclo-pirazol, composições farmacêuticas compreendendo os compostos, uso dos compostos na fabricação de medicamentos, processos para a preparação dos compostos, coleção quìmica combinatória e métodos para o tratamento de mamìferos incluindo humanos utilizando os compostos
BR0313109A (pt) Ciclobuteno-1,2-dionas 3,4-dissubstituìdas como ligandos de receptor de quimiocina de cxc
PA8493701A1 (es) Compuestos para tratar la obesidad
DE60229530D1 (de) Substituierte piperazine als modulatoren des melanocortinrezeptors
NL300202I1 (nl) Nucleotide-analogen.
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
EA200001085A1 (ru) 5-аминоиндено [1, 2-с]пиразол-4-оны в качестве противораковых и антипролиферативных агентов
DK1206484T3 (da) Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese
SE0104331D0 (sv) Novel compounds
NO20052172D0 (no) 4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter
DK441180A (da) 2-hydroxyalkyl-3,4,5-trihydroxypiperidiner deres fremstilling og anvendelse
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
DK613687D0 (da) Kondenserede heterocycliske tetrahydroaminoquinolinoler og beslaegtede forbindelser, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
FR2599036B1 (fr) Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
DK1000067T3 (da) Thiazolobenzoheterocycliske forbindelser, deres fremstilling og lægemidler indeholdende forbindelserne
IT1307786B1 (it) Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
DK583084A (da) (3-aryl-2,3-dihydrobenzofuran-3-yl)-alkylaminer, deres fremstilling og anvendelse som laegemidler
BR0205220A (pt) Derivados de fenilpiperazina, método para a preparação de um composto, composição farmacêutica, e, métodos de tratamento do mal de parkinson, e de distúrbios de cns tais como esquizofrenia, ansiedade e depressão
EP1772144A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
AR032341A1 (es) N-(2-metansulfonil-etil)-n-hidroxiformamidas, su uso en la produccion de medicamentos, composiciones farmaceuticas que las contienen, procedimiento para preparar dichos compuestos e intermediarios para su preparacion